Overview
The objective of this project is to develop novel diagnostic biomarkers of Sjögren’s disease to better characterize patient phenotypic subgroups associated with clinical features and symptoms. If successful, these biomarkers will help establish clinical diagnostic criteria which are sensitive to pre-symptomatic biologically-evident disease (i.e., early disease). Furthermore, molecular characterization of patient subpopulations, and firm understanding of their relation to clinical features, will allow alignment of critical pathways and cell types with therapeutic assets, both existing and in development. Molecular classifications will also provide improved methods for patient (severity) stratification. Overall, these data will be a useful source for understanding previous and ongoing clinical trial responses, and in the rationale design of future trials.
Learn more about this project by viewing the project one-pager.
Sjögren’s Disease Webinar
Partners
Contact
For more information about this project, please contact
For more information about supporting or becoming a partner in this project, please contact
Donate
Partner With Us
Work with the FNIH to accelerate medical breakthroughs for patients